Latest Insider Transactions at Criteo S.A. (CRTO)
This section provides a real-time view of insider transactions for Criteo S.A. (CRTO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Criteo S.A. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Criteo S.A.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 07
2022
|
Edmond Mesrobian Director |
BUY
Open market or private purchase
|
Direct |
495
+2.96%
|
$11,385
$23.86 P/Share
|
|
Nov 07
2022
|
Edmond Mesrobian Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,365
+25.4%
|
$123,395
$23.86 P/Share
|
|
Oct 25
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
40
-0.03%
|
$1,040
$26.37 P/Share
|
|
Oct 24
2022
|
Sarah Js Glickman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
53,734
-11.04%
|
$1,397,084
$26.05 P/Share
|
|
Oct 21
2022
|
Hubert De Pesquidoux Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,400
+32.05%
|
$83,200
$8.13 P/Share
|
|
Sep 12
2022
|
Megan Clarken Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,641
-0.89%
|
$105,589
$29.61 P/Share
|
|
Sep 06
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
134
-0.04%
|
$3,618
$27.36 P/Share
|
|
Aug 15
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-8.98%
|
$420,000
$28.57 P/Share
|
|
Jul 25
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
40
-0.02%
|
$920
$23.34 P/Share
|
|
Jun 13
2022
|
Megan Clarken Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,645
-0.89%
|
$83,835
$23.66 P/Share
|
|
Jun 03
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
134
-0.08%
|
$3,484
$26.36 P/Share
|
|
Apr 25
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
40
-0.02%
|
$960
$24.91 P/Share
|
|
Mar 11
2022
|
Megan Clarken Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,339
-0.57%
|
$60,814
$26.37 P/Share
|
|
Mar 03
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
275
-0.08%
|
$8,525
$31.57 P/Share
|
|
Feb 24
2022
|
Sarah Js Glickman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
147,135
+25.0%
|
-
|
|
Feb 24
2022
|
Ryan Damon Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,304
+13.78%
|
-
|
|
Feb 24
2022
|
Megan Clarken Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
203,692
+22.29%
|
-
|
|
Jan 25
2022
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
125
-0.11%
|
$4,000
$32.73 P/Share
|
|
Dec 17
2021
|
Hubert De Pesquidoux Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,349
+15.41%
|
$169,611
$39.88 P/Share
|
|
Dec 17
2021
|
Rachel Picard Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,446
+16.49%
|
$297,840
$40.62 P/Share
|
|
Dec 16
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,763
-4.31%
|
$441,283
$41.0 P/Share
|
|
Dec 16
2021
|
Ryan Damon Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,717
+5.76%
|
$316,397
$41.01 P/Share
|
|
Dec 15
2021
|
James Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,380
+8.81%
|
$170,820
$39.42 P/Share
|
|
Dec 14
2021
|
Marie Lalleman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,100
+18.58%
|
$204,000
$40.0 P/Share
|
|
Dec 14
2021
|
Nathalie Balla Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,640
+23.21%
|
$149,240
$41.34 P/Share
|
|
Dec 14
2021
|
Megan Clarken Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
135,108
-39.13%
|
$5,404,320
$40.51 P/Share
|
|
Dec 14
2021
|
Megan Clarken Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
135,108
+28.13%
|
$2,296,836
$17.73 P/Share
|
|
Dec 13
2021
|
Megan Clarken Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
43,367
-17.11%
|
$1,778,047
$41.16 P/Share
|
|
Dec 13
2021
|
Edmond Mesrobian Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,395
+24.62%
|
$139,195
$41.14 P/Share
|
|
Oct 25
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
40
-0.03%
|
$1,360
$34.75 P/Share
|
|
Jul 26
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
39
-0.03%
|
$1,521
$39.62 P/Share
|
|
May 13
2021
|
Megan Clarken Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,988
-15.07%
|
$1,619,568
$36.13 P/Share
|
|
May 13
2021
|
Megan Clarken Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,988
+13.1%
|
$809,784
$18.9 P/Share
|
|
May 07
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
53,405
-16.16%
|
$2,029,390
$38.54 P/Share
|
|
May 07
2021
|
Ryan Damon Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,938
+18.96%
|
$859,698
$21.32 P/Share
|
|
Apr 26
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
39
-0.03%
|
$1,443
$37.21 P/Share
|
|
Mar 15
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
709
-0.53%
|
$23,397
$33.0 P/Share
|
|
Mar 12
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
730
-0.54%
|
$24,090
$33.0 P/Share
|
|
Mar 11
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,400
-1.02%
|
$49,000
$35.0 P/Share
|
|
Mar 09
2021
|
Rachel Picard Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+4.45%
|
$45,088
$32.35 P/Share
|
|
Feb 25
2021
|
Megan Clarken Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,200
+30.3%
|
-
|
|
Feb 25
2021
|
Ryan Damon Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,965
+22.78%
|
-
|
|
Jan 25
2021
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
126
-0.19%
|
$2,268
$18.63 P/Share
|
|
Nov 30
2020
|
Hubert De Pesquidoux Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,300
+50.0%
|
$138,700
$19.06 P/Share
|
|
Nov 27
2020
|
Edmond Mesrobian Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+50.0%
|
$133,000
$19.89 P/Share
|
|
Nov 25
2020
|
Rachel Picard Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,917
+29.23%
|
$226,423
$19.36 P/Share
|
|
Nov 25
2020
|
Marie Lalleman Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+38.94%
|
$209,000
$19.07 P/Share
|
|
Nov 24
2020
|
James Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,270
+35.94%
|
$166,860
$18.87 P/Share
|
|
Nov 24
2020
|
Nathalie Balla Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+50.0%
|
$159,600
$19.1 P/Share
|
|
Oct 28
2020
|
Ryan Damon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
154
-0.23%
|
$2,002
$13.68 P/Share
|